Espinoza M, Aguilera A, Auxiliadora Bajo M, Codoceo R, Caravaca E, Cirugeda A, del Peso G, Hevia C, Selgas R
Servicio de Nefrología, Hospital Universitario La Paz, Madrid, Spain.
Adv Perit Dial. 1999;15:82-6.
Tumor necrosis factor alpha (TNF alpha) is usually excreted by the kidney. In dialysis patients, it accumulates. TNF alpha has been implicated in the pathogenesis of malnutrition, diabetic neuropathy, and erythropoietin resistance. We studied TNF alpha plasma levels in 49 stable peritoneal dialysis (PD) patients, with the aim of correlating those levels with the presence and severity of peripheral neuropathy, hypertrophic cardiomyopathy, and anemia. Kt/Vurea' residual renal creatinine clearance (CrC), nutritional markers, and general biochemistry were also determined. The average plasma level of TNF alpha was 67 +/- 32 pg/mL (range: 18.1-156.3 pg/mL; normal value 3-20 pg/mL). No correlation was observed between TNF alpha and KT/Vurea' but a negative correlation with CrC was seen (r: -0.37, p < 0.05). TNF alpha levels were higher in patients with neuropathy as compared to patients with normal results (72.5 +/- 32 pg/mL vs 44 +/- 22 pg/mL, p < 0.05). Patients with neuropathy also showed a lower CrC value (1.5 +/- 1.7 mL/min vs 3.9 +/- 2.6 mL/min, p < 0.01). TNF alpha levels were higher in patients with left ventricular hypertrophy (LVH) with respect to normal individuals (70.4 +/- 32 pg/mL vs 38.5 +/- 20.8 pg/mL, p < 0.05). Patients with severe LVH showed the lowest CrC value. A direct, significant relationship was found between TNF alpha levels and weekly erythropoietin dose (r: 0.41, p < 0.05). Patients with hypertriglyceridemia or taking lipid-lowering agents showed a positive linear correlation between TNF alpha and triglycerides (r = 0.7, n = 14, p < 0.05). These data suggest that accumulation of TNF alpha may contribute to the development or maintenance of some neurologic, hematologic, and cardiac complications of uremic syndrome. Loss of residual renal function conditions an increment in TNF alpha levels. These data continue to add support to the idea that TNF alpha may be considered a uremic toxin.
肿瘤坏死因子α(TNFα)通常经肾脏排泄。在透析患者中,它会蓄积。TNFα与营养不良、糖尿病性神经病变及促红细胞生成素抵抗的发病机制有关。我们研究了49例稳定的腹膜透析(PD)患者的血浆TNFα水平,目的是将这些水平与周围神经病变、肥厚型心肌病及贫血的存在和严重程度相关联。还测定了Kt/Vurea、残余肾肌酐清除率(CrC)、营养指标及一般生化指标。TNFα的平均血浆水平为67±32 pg/mL(范围:18.1 - 156.3 pg/mL;正常值3 - 20 pg/mL)。未观察到TNFα与Kt/Vurea之间存在相关性,但与CrC呈负相关(r:-0.37,p < 0.05)。与结果正常的患者相比,神经病变患者的TNFα水平更高(72.5±32 pg/mL对44±22 pg/mL,p < 0.05)。神经病变患者的CrC值也更低(1.5±1.7 mL/min对3.9±2.6 mL/min,p < 0.01)。左心室肥厚(LVH)患者的TNFα水平高于正常个体(70.4±32 pg/mL对38.5±20.8 pg/mL,p < 0.05)。严重LVH患者的CrC值最低。发现TNFα水平与每周促红细胞生成素剂量之间存在直接、显著的关系(r:0.41,p < 0.05)。高甘油三酯血症患者或服用降脂药的患者中,TNFα与甘油三酯之间呈正线性相关(r = 0.7,n = 14,p < 0.05)。这些数据表明,TNFα的蓄积可能有助于尿毒症综合征某些神经、血液及心脏并发症的发生或维持。残余肾功能丧失会导致TNFα水平升高。这些数据继续支持TNFα可被视为一种尿毒症毒素这一观点。